Measuring Serum Level of Total L Carnitine in HIE and TTN

NCT ID: NCT04546321

Last Updated: 2020-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

47 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is a comparative prospective and observational study conducted at Neonatal Intensive Care Unit (NICU) in Assiut University Children Hospital. All cases of perinatal asphyxia and TTN admitted to the NICU during the period 12-2016 to 6-2018 were included. All the included newborns were examined and the serum level of total L carnitine was measured. Then we compared the demographic data and investigation of cases with HIE with the outcome of those cases. Results: It was found that serum level of total L carnitine decreased in both HIE and TTN cases but without significant difference with mean 5.51 ± 1.30 umol/l in group I vs 6.22 ± 2.56 umol/l in group II. The male factor with changes in the serum sodium (132.63 ± 9.30) and abnormal serum creatinine level \[1.4 (0.7-15.0)\] were significantly related to the outcome of cases with HIE

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective comparative and observational study included all the full-term HIE and TTN cases admitted to NICU of the University Children Hospital during the period of December 2016 to June 2018. The newborns with perinatal asphyxia who died before admission, gestational age\<37wks and those with congenital anomalies were excluded. The study included 35 HIE Patients and 12 TTN patients. All cases were subjected to full perinatal history and clinical examination. HIE cases were classified clinically by Sarnat staging (Sarnat and Sarnat, 1976) \[10\]. HIE cases were subjected to investigations as capillary blood gases, complete blood count (CBC), and electrolytes, renal function. The demographic data and the results of HIE investigations will be correlated to the outcome. The serum level of total L carnitine was measured for both HIE and TTN cases by sending 1 ml of newborn serum frozen to be analyzed by human ELIZA (Enzyme Linked Immunosorbent Assay) kit (SinoGeneClon Biotech Co.,Ltd) within the 1st week of life and compared with each other. Normal range in males and females 17.4-58.7umol/l. the

Statistical analysis:

Data entry and data analysis were done using SPSS version 22 (Statistical Package for Social Science). Data were presented as number, percentage, mean, standard deviation and median. Chi-square and Fisher Exact tests were used to compare between qualitative variables. Independent samples t-test was used to compare quantitative variables between two groups and ANOVA test for more than two groups in case of parametric data. Mann-Whitney test was used to compare quantitative variables between groups in case of non-parametric data. P-value considered statistically significant when P \< 0.05.

Results:

The study included 35 cases of HIE (group I) and 12 cases of TTN (group II) all cases were full-term babies there was no significance between the two groups in the demographic data (sex, weight and maternal age) . There were (19) 54.3% females and (16) 47.7% males in the first group versus 33.3% females and 66.7% males in the 2nd group.The mean birth weight for the first group was 2.78 ± 0.50 kg versus 2.86 ± 0.28 kg in the second group. There were 22 cases and 11 cases delivered by cesarean section in the 1st group and the 2nd group respectively. There were 13 cases and 1 case delivered by normal vaginal delivery in group I and group II respectively. On comparison between the two groups in measuring the serum level of total L carnitine. The serum level of total L carnitine had decreased in both groups with a mean of 5.51 ± 1.30 umol/l in group I versus 6.22 ± 2.56 umol/l in group II. Then after correlation between the demographic data and investigations of cases of HIE with the outcome there was a significant correlation between male factor and death by deaths of 66% of males with HIE and also there was a significant correlation between the outcome and grade III of HIE ( 86.7% of grade III died) .There were a significant correlation between hyponatremia (132.63 ± 9.30) with death of HIE cases and abnormal serum creatinine \[1.4 (0.7-15.0)\] with death of HIE cases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Compare Between the Serum Level of Lcarnitine in HIE Cases and TTN

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIE group (I)

All fullterm newborn admitted to the NICU with Hypoxic Ischemic Encephalopathy during the study period

serum L carnitine level measuring

Intervention Type OTHER

The serum level of total L carnitine was measured for both HIE and TTN cases

TTN group(II)

All fullterm babies with Transient Tachypnea of the Newborn admitted to the NICU during the study period

serum L carnitine level measuring

Intervention Type OTHER

The serum level of total L carnitine was measured for both HIE and TTN cases

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

serum L carnitine level measuring

The serum level of total L carnitine was measured for both HIE and TTN cases

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all the full-term HIE and TTN cases admitted to NICU of the University Children Hospital during the period of December 2016 to June 2018.

Exclusion Criteria

* The newborns with perinatal asphyxia who died before admission, gestational age\<37wks and those with congenital anomalies were excluded
Minimum Eligible Age

1 Minute

Maximum Eligible Age

30 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amira Shalaby

Lecturer of Pediatrics and Neonataology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amira Shalaby

Role: PRINCIPAL_INVESTIGATOR

NICU,Assiut University Children Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Assiut U CH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Value of Transcutaneous Bilirubin Devices
NCT06232174 NOT_YET_RECRUITING